Media Summary: Lucille Accetta on how we deliver top service. In this episode the hosts dig into a $7.1 M cash‑price listing for a Bob Smith, Venture Partner, OrbiMed; Chairman, Alliance for Regenerative Medicine (Moderator) Lynelle Hoch,

The Hidden Infrastructure Behind Specialty Pharmacy With Vp Of Strategy Scott Hughes - Detailed Analysis & Overview

Lucille Accetta on how we deliver top service. In this episode the hosts dig into a $7.1 M cash‑price listing for a Bob Smith, Venture Partner, OrbiMed; Chairman, Alliance for Regenerative Medicine (Moderator) Lynelle Hoch, Ever wonder what truly happens after your doctor writes a prescription? In this episode of Medically Speaking, Dr. Eve Glazier sits ... Lucille Accetta on our leading role in the industry. Lawmakers and federal regulators accuse drug makers of inflating the price of the drug. Politico reports that UnitedHealth Group, ...

FIP's Pharmaceutical Workforce Development Goal 4 calls on countries to have training infrastructures in place to recognise ... Why underutilized U.S. biotech manufacturing capacity may become an overlooked catalyst for future pharma acquisitions. What happens when a simple coffee-shop conversation turns into a life-saving idea? In this eye-opening talk, Stephen Rider ...

Photo Gallery

The Hidden Infrastructure Behind Specialty Pharmacy with VP of Strategy Scott Hughes
The most tech-enabled specialty pharmacy
The Nursing Infrastructure Behind Home Infusion with Ryan Johnson
How to Find Hidden Specialty Pharmacy Deals – Broker Secrets Explained
The Strategic Biopharma Perspective: Scaling Science, Strategy and Success for CGTs
Behind the Counter, Beside the Bed: The Real World of Pharmacy
The nation’s #1 specialty pharmacy
Private equity activity is the lowest I've seen in my 45-year career: THL Partners' Scott Sperling
FTC set to sue 3 largest pharmacy benefit managers over insulin drug prices
The Global State of Specialty Pharmacy: Insights Across Borders
Advanced and specialist development
Video Recap: The Hidden Infrastructure Angle in Biotech M&A
Sponsored
Sponsored
View Detailed Profile
The Hidden Infrastructure Behind Specialty Pharmacy with VP of Strategy Scott Hughes

The Hidden Infrastructure Behind Specialty Pharmacy with VP of Strategy Scott Hughes

Most people see a

The most tech-enabled specialty pharmacy

The most tech-enabled specialty pharmacy

Lucille Accetta on how we deliver top service.

Sponsored
The Nursing Infrastructure Behind Home Infusion with Ryan Johnson

The Nursing Infrastructure Behind Home Infusion with Ryan Johnson

In this episode of

How to Find Hidden Specialty Pharmacy Deals – Broker Secrets Explained

How to Find Hidden Specialty Pharmacy Deals – Broker Secrets Explained

In this episode the hosts dig into a $7.1 M cash‑price listing for a

The Strategic Biopharma Perspective: Scaling Science, Strategy and Success for CGTs

The Strategic Biopharma Perspective: Scaling Science, Strategy and Success for CGTs

Bob Smith, Venture Partner, OrbiMed; Chairman, Alliance for Regenerative Medicine (Moderator) Lynelle Hoch,

Sponsored
Behind the Counter, Beside the Bed: The Real World of Pharmacy

Behind the Counter, Beside the Bed: The Real World of Pharmacy

Ever wonder what truly happens after your doctor writes a prescription? In this episode of Medically Speaking, Dr. Eve Glazier sits ...

The nation’s #1 specialty pharmacy

The nation’s #1 specialty pharmacy

Lucille Accetta on our leading role in the industry.

Private equity activity is the lowest I've seen in my 45-year career: THL Partners' Scott Sperling

Private equity activity is the lowest I've seen in my 45-year career: THL Partners' Scott Sperling

Scott

FTC set to sue 3 largest pharmacy benefit managers over insulin drug prices

FTC set to sue 3 largest pharmacy benefit managers over insulin drug prices

Lawmakers and federal regulators accuse drug makers of inflating the price of the drug. Politico reports that UnitedHealth Group, ...

The Global State of Specialty Pharmacy: Insights Across Borders

The Global State of Specialty Pharmacy: Insights Across Borders

Specialty

Advanced and specialist development

Advanced and specialist development

FIP's Pharmaceutical Workforce Development Goal 4 calls on countries to have training infrastructures in place to recognise ...

Video Recap: The Hidden Infrastructure Angle in Biotech M&A

Video Recap: The Hidden Infrastructure Angle in Biotech M&A

Why underutilized U.S. biotech manufacturing capacity may become an overlooked catalyst for future pharma acquisitions.

Pharmacy Deserts: The Healthcare Divide No One Talks About | Stephen Rider | TEDxStCloud

Pharmacy Deserts: The Healthcare Divide No One Talks About | Stephen Rider | TEDxStCloud

What happens when a simple coffee-shop conversation turns into a life-saving idea? In this eye-opening talk, Stephen Rider ...